Industry News
Pharmaceutical Industry News
Samsung Biologics has secured a…
Samsung Biologics has secured a contract manufacturing deal to run through Dec. 31, 2029, which will net the CDMO 1.8 trillion Korean won (roughly $1.3 billion). Samsung Bio noted that the contract timeline could be
You Might Have Already Fallen for MAHA’s Conspiracy Theories
How does MAHA turn some health-conscious people against all health care? We found out.
ICER has high confidence in the…
ICER has high confidence in the drugs' cost-effectiveness, but it also voiced concerns over the drugs' impact on healthcare budgets.
Endo is ramping up the next phase…
Endo is ramping up the next phase of its Dupuytren's contracture marketing drive. Not long after running its first branded ad for Xiaflex in the indication, the drugmaker has dubbed September the first annual National
¿Por qué cada vez más personas mayores mueren tras caídas?
Algunos investigadores sospechan que el aumento del consumo de medicamentos con receta puede explicar una tendencia preocupante.
By nailing the primary endpoint in…
By nailing the primary endpoint in a phase 3 trial, Eli Lilly's Bruton tyrosine kinase (BTK) inhibitor Jaypirca has come one step closer to reaching a broader group of patients with blood cancer.
RFK Jr., Rejecting Vaccine Data, Fuels Distrust of Public Health Agencies
By promoting suspicions about the institutions he oversees, critics say Robert F. Kennedy Jr. is jeopardizing public health. He says he is pursuing transparency.
Why Are More Older People Dying After Falls?
Some researchers suspect that rising prescription drug use may explain a disturbing trend.
¿Sirve la isotretinoína en dosis bajas?
Labios agrietados, piel descamada, hemorragias nasales: el fármaco trata el acné, pero sus efectos secundarios pueden ser muy molestos. ¿Sirve en dosis más bajas?
Industry watchers who cheered on…
Industry watchers who cheered on Summit Therapeutics’ claim that the first global phase 3 trial of its Akeso-partnered PD-1xVEGF drug showed consistent benefit between China and Western populations may be disappointed, although hopes for an
¿Una pastilla para curar el cerebro? Un grupo de científicos intenta probarla
Los neurólogos están explorando medicamentos que ayudarían al cerebro a recuperarse tras un accidente cerebrovascular o una lesión traumática.
The Doctors Are Real, but the Sales Pitches Are Frauds
Scammers are using A.I. tools to make it look as if medical professionals are promoting dubious health care products.
Five months after embarking on a…
Five months after embarking on a “massive testing and research effort” to root out the cause of the nation's "autism epidemic," Robert F. Kennedy Jr. is getting ready to present his findings this month.
Spending on point-of-care drug…
Spending on point-of-care drug marketing is on the rise. The revenues of members of the Point of Care Marketing Association climbed 16% last year to break the $1 billion barrier.
More than 200 employees at…
More than 200 employees at Perrigo's Bronx plant have been on strike since Sept. 2 as the company looks to expand its operations at the site to seven days a week, according to a local
The “Pledge to Champion a…
The “Pledge to Champion a Menopause-Inclusive Workplace” initially began last fall as an internal initiative, but Astellas is now rolling it out worldwide for other businesses to join, with the external launch tied to Menopause
In a familiar refrain, the…
In a familiar refrain, the European Medicines Agency is warning consumers about a 'sharp rise' in the illegitimate sale of counterfeit versions of Eli Lilly's and Novo Nordisk's diabetes and weight loss drugs.
In an amended complaint filed…
In an amended complaint filed Thursday in Delaware federal court, GSK’s legal team said the company will also seek royalties on mNexspike after leveling initial patent infringement claims against Moderna’s first COVID vaccine, Spikevax, and
AstraZeneca’s Tagrisso-chemo…
AstraZeneca's Tagrisso-chemo regimen significantly reduced the risk of death by 23% compared with Tagrisso alone in patients with previously untreated EGFR-mutated advanced non-small cell lung cancer, an updated analysis of the phase 3 Flaura2 trial
Hope, when applied with purpose…
Hope, when applied with purpose and action, can be a powerful force for driving change. In this episode of "The Top Line," Advocate Health CEO and Fierce 50 honoree Eugene Woods draws on more than